<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02707770</url>
  </required_header>
  <id_info>
    <org_study_id>15SM3060</org_study_id>
    <nct_id>NCT02707770</nct_id>
  </id_info>
  <brief_title>The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD Patients</brief_title>
  <official_title>The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Diseases Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Health Research, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College Healthcare NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary rehabilitation (PR) is an exercise program tailored for patients with chronic lung&#xD;
      disease that is a core part of the management of patients with Chronic Obstructive Pulmonary&#xD;
      Disease (COPD). Many COPD patients develop low oxygen levels (desaturation) during exercise&#xD;
      and this is often discovered when they are being evaluated for PR. Current practice is to&#xD;
      administer oxygen to COPD patients with exercise-induced desaturation, but this is based on&#xD;
      very limited evidence. This limited evidence relates to a short-term increase in exercise&#xD;
      capacity and it is not known if this translates into longer term increases in activity or&#xD;
      whether providing these patients with oxygen improves outcomes after PR.&#xD;
&#xD;
      In addition it is not known if patients given ambulatory oxygen continue to use it after&#xD;
      completing PR. Evidence for a beneficial effect of oxygen would provide a more solid evidence&#xD;
      base for its use. Conversely demonstration of no effect would allow reassessment of the use&#xD;
      of oxygen and whether the costs are justified. Therefore the aims of this study are to assess&#xD;
      the effects of oxygen on outcomes from PR and assess the usage of ambulatory oxygen following&#xD;
      completion of PR.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a randomised, single-blinded study comparing oxygen with air in Chronic&#xD;
      Obstructive Pulmonary Disease (COPD) patients undergoing Pulmonary Rehabilitation (PR).&#xD;
&#xD;
      The study subjects will be patients with a confirmed diagnosis of COPD who have been accepted&#xD;
      for PR and who are not hypoxemic at rest, but have exercise-induced desaturation (defined as&#xD;
      a fall in oxygen saturations (SaO2) ≥4% to at least &lt;90%, or any fall to a SaO2 &lt;90%) and&#xD;
      demonstrate positive improvement with use of ambulatory oxygen as per the British Thoracic&#xD;
      Society 2015 Oxygen guidelines. It is standard practice for patients to have this assessment&#xD;
      prior to commencing PR and as part of the assessment the flow rate required to increase the&#xD;
      SaO2 to ≥90% during exercise will be determined. Patients will be recruited from PR programs&#xD;
      at imperial college health care trust hospitals.&#xD;
&#xD;
      The subjects will be randomised to receive either oxygen at the flow rate determined at the&#xD;
      initial assessment to a maximum flow rate of 6 litres per minute, or room air. The subjects&#xD;
      will then undergo a standard program of PR over 6 - 8 weeks and then undergo reassessment. 20&#xD;
      patients are required in each group to detect a 30% effect size on the 6 minute walk test&#xD;
      (6MWT) with 80% power at the 5% significance level and 29 patients in each group to detect a&#xD;
      25% effect with 80% power. Therefore a minimum of 20 patients per group will be included.&#xD;
&#xD;
      Baseline assessments prior to commencing PR will include symptom and quality of life&#xD;
      assessments including Borg scale for assessment of breathlessness, Chronic Respiratory&#xD;
      Questionnaire (CRQ), COPD Assessment Tool (CAT) and the Hospital Anxiety and Depression score&#xD;
      (HAD). A 6 minute walk test (6MWT) will be carried out as this is a widely used and well&#xD;
      validated tool to measure exercise capacity. A handheld dynamometer will be used to obtain&#xD;
      more detailed measures of quadriceps muscle strength. In addition we will measure activity at&#xD;
      home during and after PR using pedometers as this has never been investigated&#xD;
      previously.These are simple devices that can be attached to patients and count the numbers of&#xD;
      steps during a day and therefore provide an estimate of activity in the home environment. A&#xD;
      yamax Digi-walker SW-200 pedometer will be used to count the number of steps taken per day.&#xD;
      Patients will be instructed to wear the device on left side of the body all the time, except&#xD;
      when sleeping or showering. Pedometer placement was standardised by placing it on the belt or&#xD;
      waistband, in the midline of the thigh, consistent with the manufacturers recommendation and&#xD;
      with other studies conducted previously. Patients will be record daily step counts on daily&#xD;
      diary cards until their final follow up.&#xD;
&#xD;
      The measures of exercise capacity at the follow up assessment will be carried out off oxygen&#xD;
      and will be carried out by an observer blinded as to whether they received oxygen or not&#xD;
      during PR. All patients will be provided with ambulatory oxygen for domiciliary use after&#xD;
      completing PR.&#xD;
&#xD;
      The hypothesis is that use of oxygen in selected patients improves exercise capacity during&#xD;
      PR. The measurable aims will be exercise capacity and on-going usage of oxygen in this&#xD;
      patient group.&#xD;
&#xD;
      Primary Objective&#xD;
&#xD;
      Assess the effects of ambulatory oxygen on outcomes from Pulmonary Rehabilitation&#xD;
&#xD;
      Secondary Objectives&#xD;
&#xD;
        1. Assess the proportion of patients that wish to continue to use ambulatory oxygen.&#xD;
&#xD;
        2. Assess the usage of ambulatory oxygen following completion of Pulmonary Rehabilitation&#xD;
&#xD;
        3. Assess whether initiation of ambulatory oxygen before or after PR has any influence on&#xD;
           adherence to usage at 8 and 12 weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Funding for the study finished before anticipated participants enrolled&#xD;
  </why_stopped>
  <start_date type="Actual">April 14, 2016</start_date>
  <completion_date type="Actual">December 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 19, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Functional Exercise Capacity</measure>
    <time_frame>0, 8weeks</time_frame>
    <description>6 Minute Walk Test (6MWT)- Distance in meters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting a Change in the Quality of Life</measure>
    <time_frame>0,8weeks</time_frame>
    <description>Chronic Respiratory Questionnaire(CRQ)- Number of Participants achieving minimal clinically important difference (MCID) in CRQ compared between baseline and follow up assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting a Change in Anxiety Score</measure>
    <time_frame>0,8weeks</time_frame>
    <description>Hospital anxiety and depression score- Anxiety component (HADS-A)-Numbers of participants achieving Minimal clinically important difference in HADS-A compared between baseline and follow up assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Change in Depression Score</measure>
    <time_frame>0,8weeks</time_frame>
    <description>Hospital anxiety and depression score- Depression component (HADS-D)-Numbers of participants achieving Minimal clinically important difference in HADS-D compared between baseline and follow up assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Change in Chronic Obstructive Pulmonary Diseases Assessment Test (CAT)</measure>
    <time_frame>0,8weeks</time_frame>
    <description>Chronic Obstructive Pulmonary diseases Assessment Test (CAT score)-Numbers of participants achieving Minimal clinically important difference in CAT score compared between baseline and follow up assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Reporting Change in Physical Activity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Pedometer- Number of step counts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Change in Quadriceps Muscle Strength</measure>
    <time_frame>0,8 weeks</time_frame>
    <description>Handheld Muscle testing- Number of participants achieving Minimal clinical important difference in quadriceps muscle strength compared between baseline and follow up assessment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Chronic Obstructive Pulmonary Diseases</condition>
  <arm_group>
    <arm_group_label>Ambulatory oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Room air</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patient will breath on room air during pulmonary rehabilitation programme</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pulmonary Rehabilitation</intervention_name>
    <arm_group_label>Ambulatory oxygen</arm_group_label>
    <arm_group_label>Room air</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. A confirmed diagnosis of Chronic Obstructive Pulmonary Disease (COPD)&#xD;
&#xD;
          2. Fulfil the clinical criteria for Pulmonary Rehabilitation (PR)&#xD;
&#xD;
          3. Demonstrate exercise-induced desaturation (defined as a fall in SaO2 ≥4% to at least&#xD;
             &lt;90%, or any fall to a SaO2 &lt;90%) and demonstrate positive improvement with use of&#xD;
             ambulatory oxygen as per the British Thoracic Society 2015 Oxygen Guidelines&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Use of long term oxygen therapy&#xD;
&#xD;
          2. Unable to provide informed consent&#xD;
&#xD;
          3. Significant respiratory disease other than COPD&#xD;
&#xD;
          4. Any patient needing more than 6 litres per minute oxygen to correct desaturation&#xD;
&#xD;
          5. Severe desaturation: SaO2 &lt; 80% during 6 Minute Walk Test&#xD;
&#xD;
          6. Any absolute contraindication to Pulmonary Rehabilitation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vijayaragavan Padmanaban, MPT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial healthcare NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Marys Hospital</name>
      <address>
        <city>London</city>
        <zip>W2 21NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 23, 2016</study_first_submitted>
  <study_first_submitted_qc>March 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2016</study_first_posted>
  <results_first_submitted>January 29, 2021</results_first_submitted>
  <results_first_submitted_qc>March 3, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 30, 2021</results_first_posted>
  <last_update_submitted>March 3, 2021</last_update_submitted>
  <last_update_submitted_qc>March 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD, pulmonary rehabilitation, ambulatory oxygen therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 4, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT02707770/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ambulatory Oxygen</title>
          <description>Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)&#xD;
Pulmonary Rehabilitation</description>
        </group>
        <group group_id="P2">
          <title>Room Air</title>
          <description>Patient will breath on room air during pulmonary rehabilitation programme&#xD;
Pulmonary Rehabilitation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9">One patient withdrew from the study following consent, initial assessment and randomisation</participants>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ambulatory Oxygen</title>
          <description>Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)</description>
        </group>
        <group group_id="B2">
          <title>Room Air</title>
          <description>Patient will breath on room air during pulmonary rehabilitation programme</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73" lower_limit="54" upper_limit="80"/>
                    <measurement group_id="B2" value="72" lower_limit="60" upper_limit="90"/>
                    <measurement group_id="B3" value="72.5" lower_limit="54" upper_limit="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Functional Exercise Capacity</title>
        <description>6 Minute Walk Test (6MWT)- Distance in meters</description>
        <time_frame>0, 8weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ambulatory Oxygen</title>
            <description>Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)&#xD;
Pulmonary Rehabilitation</description>
          </group>
          <group group_id="O2">
            <title>Room Air</title>
            <description>Patient will breath on room air during pulmonary rehabilitation programme&#xD;
Pulmonary Rehabilitation</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Functional Exercise Capacity</title>
          <description>6 Minute Walk Test (6MWT)- Distance in meters</description>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline -0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="332" lower_limit="170" upper_limit="430"/>
                    <measurement group_id="O2" value="335" lower_limit="140" upper_limit="500"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post PR - 8weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="346" lower_limit="200" upper_limit="430"/>
                    <measurement group_id="O2" value="340" lower_limit="140" upper_limit="510"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting a Change in the Quality of Life</title>
        <description>Chronic Respiratory Questionnaire(CRQ)- Number of Participants achieving minimal clinically important difference (MCID) in CRQ compared between baseline and follow up assessment.</description>
        <time_frame>0,8weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ambulatory Oxygen</title>
            <description>Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)</description>
          </group>
          <group group_id="O2">
            <title>Room Air</title>
            <description>Patient will breath on room air during pulmonary rehabilitation programme</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting a Change in the Quality of Life</title>
          <description>Chronic Respiratory Questionnaire(CRQ)- Number of Participants achieving minimal clinically important difference (MCID) in CRQ compared between baseline and follow up assessment.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting a Change in Anxiety Score</title>
        <description>Hospital anxiety and depression score- Anxiety component (HADS-A)-Numbers of participants achieving Minimal clinically important difference in HADS-A compared between baseline and follow up assessment.</description>
        <time_frame>0,8weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ambulatory Oxygen</title>
            <description>Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)</description>
          </group>
          <group group_id="O2">
            <title>Room Air</title>
            <description>Patient will breath on room air during pulmonary rehabilitation programme</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting a Change in Anxiety Score</title>
          <description>Hospital anxiety and depression score- Anxiety component (HADS-A)-Numbers of participants achieving Minimal clinically important difference in HADS-A compared between baseline and follow up assessment.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Change in Depression Score</title>
        <description>Hospital anxiety and depression score- Depression component (HADS-D)-Numbers of participants achieving Minimal clinically important difference in HADS-D compared between baseline and follow up assessment.</description>
        <time_frame>0,8weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ambulatory Oxygen</title>
            <description>Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)</description>
          </group>
          <group group_id="O2">
            <title>Room Air</title>
            <description>Patient will breath on room air during pulmonary rehabilitation programme</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Change in Depression Score</title>
          <description>Hospital anxiety and depression score- Depression component (HADS-D)-Numbers of participants achieving Minimal clinically important difference in HADS-D compared between baseline and follow up assessment.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Change in Chronic Obstructive Pulmonary Diseases Assessment Test (CAT)</title>
        <description>Chronic Obstructive Pulmonary diseases Assessment Test (CAT score)-Numbers of participants achieving Minimal clinically important difference in CAT score compared between baseline and follow up assessment.</description>
        <time_frame>0,8weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ambulatory Oxygen</title>
            <description>Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)</description>
          </group>
          <group group_id="O2">
            <title>Room Air</title>
            <description>Patient will breath on room air during pulmonary rehabilitation programme</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Change in Chronic Obstructive Pulmonary Diseases Assessment Test (CAT)</title>
          <description>Chronic Obstructive Pulmonary diseases Assessment Test (CAT score)-Numbers of participants achieving Minimal clinically important difference in CAT score compared between baseline and follow up assessment.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Reporting Change in Physical Activity</title>
        <description>Pedometer- Number of step counts</description>
        <time_frame>8 weeks</time_frame>
        <population>Due to technical problems identified with accuracy of device, this outcome measure was excluded from study</population>
        <group_list>
          <group group_id="O1">
            <title>Ambulatory Oxygen</title>
            <description>Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)&#xD;
Pulmonary Rehabilitation</description>
          </group>
          <group group_id="O2">
            <title>Room Air</title>
            <description>Patient will breath on room air during pulmonary rehabilitation programme&#xD;
Pulmonary Rehabilitation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Reporting Change in Physical Activity</title>
          <description>Pedometer- Number of step counts</description>
          <population>Due to technical problems identified with accuracy of device, this outcome measure was excluded from study</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Change in Quadriceps Muscle Strength</title>
        <description>Handheld Muscle testing- Number of participants achieving Minimal clinical important difference in quadriceps muscle strength compared between baseline and follow up assessment</description>
        <time_frame>0,8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ambulatory Oxygen</title>
            <description>Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)&#xD;
Pulmonary Rehabilitation</description>
          </group>
          <group group_id="O2">
            <title>Room Air</title>
            <description>Patient will breath on room air during pulmonary rehabilitation programme&#xD;
Pulmonary Rehabilitation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Change in Quadriceps Muscle Strength</title>
          <description>Handheld Muscle testing- Number of participants achieving Minimal clinical important difference in quadriceps muscle strength compared between baseline and follow up assessment</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event monitored throughout the study period ( Up to end of final follow up, approximately 8 weeks)</time_frame>
      <desc>Definition of AE is not different to clinicaltrials.gov definitions</desc>
      <group_list>
        <group group_id="E1">
          <title>Ambulatory Oxygen</title>
          <description>Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)</description>
        </group>
        <group group_id="E2">
          <title>Room Air</title>
          <description>Patient will breath on room air during pulmonary rehabilitation programme</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Due to study terminated prematurely, unable to recruit the intended number of participants and complete extra follow ups as proposed in the study protocol.&#xD;
Due to technical issue with pedometer device and validity of measurements, physical activity measurement was not included or analysed as part of the secondary outcome measure.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>vijay padmanaban</name_or_title>
      <organization>Imperial college healthcare NHS trust</organization>
      <phone>02033122349</phone>
      <email>vijay.padmanaban@nhs.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

